| Literature DB >> 36010444 |
Gayathri Balakrishnan1, Renée Goodrich Schneider1.
Abstract
The selection of sustainable crops adaptable to the rapidly changing environment, which also cater to the dietary needs of the growing population, is a primary challenge in meeting food security. Grains from ancient crops such as amaranth, quinoa, and millets are positioned to address this challenge and hence have gained dietary predominance among cereals and pseudocereals due to their nutritional value and energy efficiency. From a nutritional perspective, they are recognized for their complete protein, phenolic compounds and flavonoids, prebiotic fibers, and essential micronutrients, including minerals and vitamins. Bioactive peptides from their proteins have shown antihypertensive, antidiabetic, antioxidant, and anticancer properties. The nutritional diversity of these grains makes them a preferred choice over traditional cereals for developing healthy, sustainable food products such as plant-based dairy, vegan meats, and gluten-free products. With growing consumer awareness about sustainability and health, the categories mentioned above are transitioning from 'emerging' to 'mainstream'; however, there is still a significant need to include such healthy grains to fulfill the nutritional gap. This review article emphasizes the health benefits of amaranth, quinoa, and millet grains and discusses the recent research progress in understanding their application in new sustainable food categories. The challenges associated with their incorporation into novel foods and future research directions are also provided.Entities:
Keywords: ancient grains; bioactive peptides; cereals; dairy-free; food security; gluten-free; health; plant-based food; protein; sustainable
Year: 2022 PMID: 36010444 PMCID: PMC9407507 DOI: 10.3390/foods11162442
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Figure 1Agricultural and nutritional benefits of amaranth, quinoa, and millets.
Protein and amino acid profile of ancient grains.
| Ancient Grain | Amaranth | Quinoa | Finger Millet | Foxtail Millet | Proso Millet | FAO/WHO Amino Acid |
|---|---|---|---|---|---|---|
| Protein | 13.6 | 14.1 | 9.8 | 15.9 | 14.4 | |
| Essential amino acids (g/100 g protein) | ||||||
| Histidine | 3.0 | 2.7 | 2.8 | 2.3 | 2.4 | 1.5 |
| Isoleucine | 3.9 | 3.1 | 5.2 | 5.1 | 4.9 | 3.0 |
| Leucine | 6.2 | 6 | 11.7 | 16.0 | 14.0 | 5.9 |
| Lysine | 5.7 | 4.8 | 3.1 | 1.9 | 1.7 | 4.5 |
| Methionine+ Cystine | 4.6 | 3.3 | 5.9 | 5.1 | 5.1 | 2.2 |
| Phenylalanine + Tyrosine | 5.4 | 6.3 | 10.3 | 10.0 | 10.8 | 3.8 |
| Threonine | 5.1 | 3.7 | 5.2 | 4.5 | 4.1 | 2.3 |
| Tryptophan | 0.9 | 0.9 | 1.3 | 1.1 | 0.6 | 0.6 |
| Valine | 5.9 | 3.7 | 8.2 | 6.3 | 6.4 | 3.9 |
Adapted from: Ravindran, et al. [26], Malleshi et al. [27], Parameshwaran et al. [28], Nowak et al. [29], and Saguro Nieto et al. [30].
Figure 2Health benefits of bioactive peptides extracted from amaranth, quinoa, and millet proteins.
Summary of recent studies that assessed the health benefits of ancient grain bioactive peptides after in vitro gastrointestinal digestion.
| Ancient Grain | Health Benefits | Research Finding | References |
|---|---|---|---|
| Amaranth | Antioxidant, anti- inflammatory properties | Germinated amaranth released bioactive peptides that reduced nitric oxide production and showed antioxidant effects | [ |
| Anti-cancer | Antiproliferation, induction of apoptosis, and necrosis of cancer cells | [ | |
| Antioxidant | Intracellular reduction of the reactive oxygen species | [ | |
| Antioxidant and anti-cancer | Radical scavenging activity, inhibition of cancel cell growth, DNA fragmentation leading to apoptosis | [ | |
| Quinoa | Antioxidant and anti-cancer properties | Seventeen peptides with antioxidant activity tested using ORAC, and inhibition of tumor cell viability in cancer cell lines | [ |
| Anti-hypertension | Low molecular peptides containing arginine, phenyalanine, and proline that inhibited ACE activity in vitro, and blood pressure in hypertensive rats | [ | |
| Anti-cancer | Smaller peptides <5 kDa with antiproliferative activity modulated by HDAC1 inhibition | [ | |
| Antidiabetic | Three peptides were identified from quinoa globulin proteins. Antidiabetic activity due to DPP-IV, α-amylase, and α-glucosidase inhibition. | [ | |
| Finger Millet | Antioxidant activity | Two peptides with aromatic and hydrophobic amino acids that stabilized free radicals | [ |
| Foxtail millet | Anti-inflammatory | Peptides from germinated and heat-treated millets that were effective against biomarkers of inflammation and oxidative stress | [ |
| Protection against intestinal inflammation | Presence of peptides that effectively inhibited inflammatory factors such as NF-kB, interleukin-6 | [ | |
| Proso millet | Anti-inflammatory and lipase inhibition | Glycine-rich peptides with lipoxygenase and cyclooxygenase inhibitory activity | [ |
Mineral content of ancient and common grains.
| Minerals (mg/100 g) | Amaranth | Quinoa | Finger Millet | Foxtail Millet | Proso | Wheat | Rice | Corn |
|---|---|---|---|---|---|---|---|---|
| Copper | 0.51 | 0.59 | 4 | 3 | 4 | 0.41 | 0.3 | 0.054 |
| Manganese | 1.51 | 1.95 | 5 | 26 | 19 | 4.07 | 2.84 | 0.163 |
| Iron | 9.62 | 5.46 | 5 | 19 | 20 | 3.6 | 1.5 | 0.52 |
| Zinc | 5.55 | 2.93 | 2 | 9 | 11 | 2.6 | 1.91 | 0.46 |
| Magnesium | 231 | 197 | 130 | 100 | 120 | 137 | 124 | 37 |
| Calcium | 165 | 44 | 240 | 30 | 30 | 34 | 10 | 2 |
| Phosphorus | 527 | 468 | 240 | 270 | 260 | 357 | 319 | 89 |
| Potassium | 530 | 664 | 570 | 400 | 370 | 363 | 265 | 270 |
Adapted from: Ravindran [73], Nascimento et al. [74], USDA [75].
Clinical trials on amaranth, quinoa, and millet products to understand their antidiabetic, anti-obesity, anticholesterolemic, and anti-inflammatory potential.
| Ancient Grain | Key Biomarkers Measured | Number of | Intervention Period | Significant | Reference |
|---|---|---|---|---|---|
| Amaranth | Plasma lipids | 22 | No | [ | |
| Diabetes markers (insulin, leptin, resistin, visfatin, PAI-1) | 62 | 3 months | Yes | [ | |
| Quinoa | Lipid profile (total cholesterol, triglycerides, HDL, LDL)) | 50 | 12 weeks | Yes (triglycerides) | [ |
| Glucose | No | ||||
| Hormones (leptin, adiponectin, insulin, C-peptide | No | ||||
| Lipid profile (total cholesterol, triglycerides, HDL, LDL) | 27 | 120 to 200 days | Yes | [ | |
| Glucose | No | ||||
| Lipid profile (total cholesterol, triglycerides, HDL) | 40 | 4 weeks | Yes (total cholesterol and LDL) | [ | |
| Serum antioxidants | No | ||||
| Serum PUFA | No | ||||
| Finger millet | Plasma antioxidants | 18 | 8 weeks | Yes | [ |
| Cholesterol | No | ||||
| Glucose | No | ||||
| Glucose | 30 | 60 days | Yes | [ | |
| Lipid profile (total cholesterol, triglycerides, HDL, LDL, VLDL) | Yes (except for triglycerides and VLDL) | ||||
| Foxtail millet | Glucose | 64 | 12 weeks | Yes | [ |
| Lipid profile (total cholesterol, triglycerides, HDL, LDL) | Yes (HDL and LDL) | ||||
| Cytokine (IL-6, TNF-α) | Yes | ||||
| Hormones (leptin, adiponectin, GLP-1) | Yes (only for leptin) | ||||
| Blood pressure | Yes (diastolic) | ||||
| Blood pressure | 45 | 12 weeks | Yes | [ | |
| RAAS (renin-angiotensin-aldosterone system) | No | ||||
| Lipid profile (total cholesterol, triglycerides, HDL, LDL) | No | ||||
| Fasting glucose | Yes | ||||
| Barnyard millet | Glucose | 15 (9 diabetic and 6 non-diabetic) | 28 days | Yes (only among diabetic participants) | [ |
| Lipid profile | |||||
| Millets (foxtail, sorghum, and finger millet) | Glucose | 150 | NA | Yes | [ |
| Lipid profile |